You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Multiple Sclerosis Journal

Impact Factor: 5.0 / 5-Year Impact Factor: 5.2

Journal Homepage Submission guidelines

Restricted access

Other

First published online 2009-04

Re: Early relapses after the first dose of natalizumab in active multiple sclerosis

, , and

Volume 15, Issue 4

https://doi.org/10.1177/1352458508100036

Abstract

Get full access to this article

View all access options for this article.

References

1.

1 Centonze D Furlan R Gasperini C Salvetti M Battistini L . Early relapses after the first dose of natalizumab in active multiple sclerosis patients. Mult Scler 2008; 14: 1137–1138.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Advanced MRI measures like DTI or fMRI should be outcome measures in future clinical trials – NO

Retricted access

Clinical course of multiple sclerosis: A nationwide cohort study

Retricted access

A Parallel-Group Comparison of Budesonide and Beclomethasone Dipropionate for the Treatment of Perennial Allergic Rhinitis in Adults

Retricted access

Methylprednisolone treatment in multiple sclerosis: effect of treatment,pharmacokinetics,future